Section 32 — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.
BiotechDeep TechDigital HealthMedical Devices
Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)inDamien McDevitt(President and Chief Executive Officer)in
Co-investorsARCH Venture PartnersLifeforce CapitalOrbiMedDomain AssociatesEDB InvestmentsFrazier Life Sciences+4 more
WithMe provides amenity solutions for multifamily properties and residential communities, featuring branded offerings like PrintWithMe for printing services and SipWithMe for beverage amenities.
CleantechConsumerHardwareImpact & Social GoodIoTPropTechSaaSChicago, US
Jonathan Treble(Founder)inWilliam A. Reid(Executive Officer)Jonathan Jenkins(Executive Officer, Director, Promoter)
BoardZach Ware(Director)inEric Salo(Director)Danielle Jenkins(Director)
Co-investorsGreat North VenturesOak HC/FTOMERS VenturesVTF Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.